Leclaza (Lazertinib): Treatment for EGFR Mutant Lung Cancer - Mechanism of Action, Efficacy, Side Effects, and Dosage
Hello, this is Ilwon Station Exit 1 Pharmacy! Today, we will learn more about the third-generation non-small cell lung cancer (NSCLC) treatment that South Korea is proud of, Leclaza (Lazertinib). Leclaza is emerging as a new hope for patients and t…